Table 3.
Genes significantly upregulated (>1.5-fold, P<0.1) by the combination of HGF and VEGF at 24 h
| Sequence derived from | Gene symbol | Description | Ratio of HGF–VEGF/basal | P-value | Ratio of VEGF/basal | P-value | Ratio of HGF/basal | P-value |
|---|---|---|---|---|---|---|---|---|
| NM_000014.3 | A2M | Alpha-2-macroglobulin | 28.2 | <0.01 | 19.5 | <0.01 | 2.5 | 0.29 |
| NM_000675.2 | ADORA2A | Adenosine A2a receptor | 2.2 | <0.01 | 1.5 | 0.16 | 1.3 | 0.29 |
| NM_001621.2 | AHR | Aryl hydrocarbon receptor | 1.7 | <0.01 | 1.3 | 0.07 | 1.3 | <0.01 |
| AF187858.1 | ANGPT2 | Angiopoietin 2 | 5.9 | <0.01 | 3.8 | <0.01 | 1.9 | <0.01 |
| NM_001147.1 | ANGPT2 | Angiopoietin 2 | 6.0 | <0.01 | 4.1 | <0.01 | 1.7 | 0.05 |
| AF007150.1 | ANGPTL2 | Angiopoietin-like 2 | 1.9 | <0.01 | 1.9 | <0.01 | 1.1 | 0.33 |
| NM_012098.1 | ANGPTL2 | Angiopoietin-like 2 | 2.2 | 0.04 | 1.6 | 0.23 | 1.4 | 0.45 |
| AF007150.1 | ANGPTL2 | Angiopoietin-like 2 | 1.6 | <0.01 | 1.4 | 0.11 | 1.0 | 0.79 |
| NM_006305.1 | ANP32A | Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A | 1.5 | 0.01 | 1.0 | 0.87 | 1.3 | 0.15 |
| AF149794.1 | APAF1 | Apoptotic protease activating factor | 1.5 | <0.01 | 1.0 | 0.86 | 1.0 | 0.93 |
| AB000815.1 | ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | 1.6 | 0.06 | 1.3 | 0.72 | 1.6 | 0.35 |
| NM_006716.1 | ASK | Activator of S phase kinase | 1.8 | 0.03 | 1.4 | 0.18 | 1.1 | 0.79 |
| AI735391 | BIKE | BMP-2-inducible kinase | 2.4 | 0.08 | 2.1 | 0.09 | 1.8 | 0.29 |
| AB028869.1 | BIRC5 | Baculoviral IAP repeat-containing 5 (survivin) | 1.8 | <0.01 | 1.3 | 0.14 | 1.2 | 0.11 |
| AA648913 | BIRC5 | Baculoviral IAP repeat-containing 5 (survivin) | 2.6 | <0.01 | 1.9 | 0.08 | 1.5 | 0.16 |
| NM_001168.1 | BIRC5 | Baculoviral IAP repeat-containing 5 (survivin) | 2.2 | <0.01 | 1.7 | <0.01 | 1.3 | 0.17 |
| NM_016098.1 | BRP44L | Brain protein 44-like | 1.8 | <0.01 | 1.5 | 0.01 | 1.1 | 0.22 |
| AF043294.2 | BUB1 | BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) | 2.3 | <0.01 | 1.9 | <0.01 | 1.3 | 0.17 |
| NM_001211.2 | BUB1B | BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) | 2.0 | <0.01 | 1.7 | <0.01 | 1.2 | 0.21 |
| W72082 | C1QR1 | Complement component 1 q subcomponent receptor 1 | 1.5 | 0.08 | 1.3 | 0.32 | 1.1 | 0.72 |
| AF098158.1 | C20orf1 | Chromosome 20 open reading frame 1 | 2.1 | <0.01 | 1.6 | 0.04 | 1.3 | 0.2 |
| U17473.1 | CALCRL | Calcitonin receptor-like | 1.8 | <0.01 | 1.1 | 0.56 | 1.4 | <0.01 |
| NM_005795.1 | CALCRL | Calcitonin receptor-like | 1.5 | <0.01 | 1.0 | 0.87 | 1.3 | 0.05 |
| N25325 | CALM1 | Calmodulin 1 (phosphorylase kinase delta) | 1.6 | <0.01 | 1.3 | 0.15 | 1.0 | 0.96 |
| BF439983 | CASP8 | Caspase 8 apoptosis-related cysteine protease | 1.9 | 0.06 | 1.8 | 0.04 | 1.6 | 0.24 |
| NM_004166.1 | CCL14 | Chemokine (C–C motif) ligand 14 | 2.6 | <0.01 | 1.5 | 0.03 | 1.9 | <0.01 |
| NM_006273.2 | CCL7 | Chemokine (C–C motif) ligand 7 | 3.2 | 0.08 | 1.0 | 0.99 | 1.0 | 1 |
| AF112857.1 | CCNE2 | Cyclin E2 | 2.2 | <0.01 | 1.6 | 0.08 | 1.0 | 0.88 |
| U17105.1 | CCNF | Cyclin F | 2.8 | 0.01 | 1.4 | 0.48 | 1.0 | 0.97 |
| AF064103.1 | CDC14A | CDC14 cell division cycle 14 homolog a (S. cerevisiae) | 2.5 | <0.01 | 1.9 | 0.13 | 1.8 | 0.19 |
| AF064103.1 | CDC14A | CDC14 cell division cycle 14 homolog a (S. cerevisiae) | 3.5 | <0.01 | 2.5 | 0.16 | 1.6 | 0.55 |
| NM_003672.1 | CDC14A | CDC14 cell division cycle 14 homolog A (S. cerevisiae) | 2.2 | <0.01 | 1.7 | 0.02 | 1.1 | 0.75 |
| AL524035 | CDC2 | Cell division cycle 2 G1 to S and G2 to M | 2.5 | <0.01 | 2.0 | <0.01 | 1.2 | 0.07 |
| NM_001786.1 | CDC2 | Cell division cycle 2 G1 to S and G2 to M | 2.5 | <0.01 | 1.9 | <0.01 | 1.2 | 0.26 |
| D88357.1 | CDC2 | Cell division cycle 2 G1 to S and G2 to M | 3.0 | <0.01 | 2.1 | <0.01 | 1.3 | 0.32 |
| NM_001255.1 | CDC20 | CDC20 cell division cycle 20 homolog (S. cerevisiae) | 1.9 | <0.01 | 1.5 | 0.04 | 1.5 | 0.06 |
| AI343459 | CDC25A | Cell division cycle 25A | 3.4 | <0.01 | 3.1 | 0.1 | 1.3 | 0.68 |
| NM_021873.1 | CDC25B | Cell division cycle 25B | 1.6 | <0.01 | 1.5 | 0.01 | 1.1 | 0.39 |
| NM_001790.2 | CDC25C | Cell division cycle 25C | 1.6 | <0.01 | 1.4 | 0.07 | 1.1 | 0.59 |
| NM_003504.1 | CDC45L | CDC45 cell division cycle 45-like (S. cerevisiae) | 2.1 | <0.01 | 2.1 | 0.02 | 1.0 | 0.94 |
| U77949.1 | CDC6 | CDC6 cell division cycle 6 homolog (S. cerevisiae) | 2.0 | <0.01 | 1.6 | 0.14 | 0.9 | 0.55 |
| NM_001254.1 | CDC6 | CDC6 cell division cycle 6 homolog (S. cerevisiae) | 1.9 | <0.01 | 1.8 | <0.01 | 1.0 | 0.9 |
| AB012305.1 | CDK2 | Cyclin-dependent kinase 2 | 1.9 | <0.01 | 1.3 | 0.45 | 1.3 | 0.51 |
| U17074.1 | CDKN2C | Cyclin-dependent kinase inhibitor 2C (p18 inhibits CDK4) | 2.6 | 0.08 | 1.8 | 0.58 | 1.9 | 0.32 |
| NM_001262.1 | CDKN2C | Cyclin-dependent kinase inhibitor 2C (p18 inhibits CDK4) | 1.8 | 0.01 | 1.4 | 0.18 | 1.3 | 0.42 |
| AF213033.1 | CDKN3 | Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) | 1.6 | 0.03 | 1.3 | 0.3 | 1.3 | 0.25 |
| U30872.1 | CENPF | Centromere protein F, 350/400 ka (mitosin) | 1.6 | <0.01 | 1.3 | 0.06 | 1.3 | 0.08 |
| NM_005196.1 | CENPF | Centromere protein F, 350/400 ka (mitosin) | 1.9 | <0.01 | 1.5 | 0.03 | 1.2 | 0.28 |
| AF041461.1 | CFLAR | CASP8 and FADD-like apoptosis regulator | 1.7 | 0.01 | 0.9 | 0.51 | 1.1 | 0.49 |
| NM_003879.1 | CFLAR | CASP8 and FADD-like apoptosis regulator | 1.5 | <0.01 | 1.0 | 0.98 | 1.0 | 0.83 |
| AF009619.1 | CFLAR | CASP8 and FADD-like apoptosis regulator | 1.5 | 0.02 | 0.9 | 0.66 | 1.0 | 0.88 |
| X06130.1 | CHC1 | Chromosome condensation 1 | 1.7 | 0.01 | 1.0 | 0.9 | 1.2 | 0.45 |
| NM_001826.1 | CKS1B | CDC28 protein kinase regulatory subunit 1B | 1.9 | <0.01 | 1.5 | <0.01 | 1.3 | 0.14 |
| AF053640.1 | CSE1L | CSE1 chromosome segregation 1-like (yeast) | 1.7 | <0.01 | 1.5 | 0.01 | 1.2 | 0.14 |
| AF053641.1 | CSE1L | CSE1 chromosome segregation 1-like (yeast) | 1.5 | <0.01 | 1.3 | 0.05 | 1.1 | 0.26 |
| NM_022646.1 | CSH2 | Chorionic somatomammotropin hormone 2 | 3.3 | 0.09 | 1.7 | 0.63 | 1.6 | 0.64 |
| AJ224869 | CXCR4 | Chemokine (C–X–C motif) receptor 4 | 3.1 | <0.01 | 2.7 | <0.01 | 1.4 | <0.01 |
| L01639.1 | CXCR4 | Chemokine (C–X–C motif) receptor 4 | 4.5 | <0.01 | 3.2 | <0.01 | 1.6 | <0.01 |
| AF348491.1 | CXCR4 | Chemokine (C–X–C motif) receptor 4 | 4.1 | <0.01 | 2.8 | <0.01 | 1.4 | <0.01 |
| U33833.1 | DDX11 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae) | 2.0 | <0.01 | 1.4 | 0.42 | 0.7 | 0.65 |
| NM_004399.1 | DDX11 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae) | 1.5 | 0.04 | 1.9 | 0.03 | 1.0 | 0.73 |
| R60068 | DDX3 | DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3 | 1.5 | <0.01 | 0.9 | 0.73 | 1.3 | 0.09 |
| NM_001930.2 | DHPS | Deoxyhypusine synthase | 1.6 | 0.05 | 1.8 | 0.13 | 1.4 | 0.3 |
| NM_007309.1 | DIAPH2 | Diaphanous homolog 2 (Drosophila) | 2.0 | <0.01 | 2.3 | <0.01 | 1.1 | 0.47 |
| NM_006729.1 | DIAPH2 | Diaphanous homolog 2 (Drosophila) | 1.9 | <0.01 | 2.3 | <0.01 | 1.0 | 0.83 |
| AJ010395 | DKC1 | Dyskeratosis congenita 1, dyskerin | 1.6 | 0.1 | 1.3 | 0.48 | 1.2 | 0.64 |
| BC003541.1 | DOK4 | Docking protein 4 | 1.5 | 0.08 | 1.8 | 0.11 | 1.4 | 0.32 |
| NM_012145.1 | DTYMK | Deoxythymidylate kinase (thymidylate kinase) | 2.5 | 0.03 | 2.2 | 0.13 | 1.3 | 0.5 |
| NM_001394.2 | DUSP4 | Dual specificity phosphatase 4 | 3.5 | <0.01 | 2.9 | 0.03 | 1.4 | 0.3 |
| BC002671.1 | DUSP4 | Dual specificity phosphatase 4 | 3.4 | <0.01 | 2.3 | 0.11 | 1.5 | 0.31 |
| BC003143.1 | DUSP6 | Dual specificity phosphatase 6 | 1.7 | <0.01 | 1.2 | 0.15 | 1.0 | 0.66 |
| BC005047.1 | DUSP6 | Dual specificity phosphatase 6 | 2.3 | <0.01 | 1.3 | 0.23 | 1.1 | 0.69 |
| BC003143.1 | DUSP6 | Dual specificity phosphatase 6 | 1.5 | <0.01 | 1.2 | 0.03 | 1.0 | 0.96 |
| AV702405 | EBP | Emopamil binding protein (sterol isomerase) | 1.7 | <0.01 | 1.3 | 0.15 | 1.2 | 0.14 |
| NM_006579.1 | EBP | Emopamil binding protein (sterol isomerase) | 1.7 | <0.01 | 1.5 | 0.01 | 1.1 | 0.59 |
| AF061192.1 | ED1 | Ectodermal dysplasia 1, anhidrotic | 3.6 | 0.08 | 1.9 | 0.59 | 1.5 | 0.76 |
| NM_001964.1 | EGR1 | Early growth response 1 | 1.5 | 0.01 | 1.7 | 0.08 | 1.4 | 0.18 |
| BF445047 | EMP1 | Epithelial membrane protein 1 | 1.7 | <0.01 | 1.6 | 0.04 | 1.0 | 0.97 |
| NM_001424.1 | EMP2 | Epithelial membrane protein 2 | 1.7 | <0.01 | 1.6 | 0.02 | 1.1 | 0.72 |
| NM_001776.1 | ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase 1 | 7.1 | <0.01 | 5.9 | <0.01 | 2.4 | 0.08 |
| U87967.1 | ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase 1 | 8.1 | <0.01 | 4.4 | 0.03 | 2.0 | 0.43 |
| AV717590 | ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase 1 | 2.6 | <0.01 | 1.8 | 0.08 | 1.1 | 0.77 |
| NM_007036.2 | ESM1 | Endothelial cell-specific molecule 1 | 2.1 | <0.01 | 2.4 | <0.01 | 1.0 | 0.43 |
| NM_005238.1 | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 1.6 | 0.01 | 1.1 | 0.82 | 1.1 | 0.76 |
| NM_004629.1 | FANCG | Fanconi anemia, complementation group G | 1.7 | <0.01 | 1.7 | <0.01 | 1.2 | 0.24 |
| NM_004117.1 | FKBP5 | FK506 binding protein 5 | 6.9 | <0.01 | 3.3 | 0.07 | 3.7 | 0.03 |
| U01134.1 | FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 2.6 | 0.01 | 0.9 | 0.85 | 1.1 | 0.76 |
| NM_021953.1 | FOXM1 | Forkhead box M1 | 3.0 | <0.01 | 2.2 | <0.01 | 1.3 | 0.34 |
| NM_002039.1 | GAB1 | GRB2-associated binding protein 1 | 1.6 | 0.02 | 1.3 | 0.45 | 1.0 | 1 |
| NM_022560.1 | GH1 | Growth hormone 1 | 3.0 | 0.1 | 3.5 | 0.03 | 3.5 | 0.1 |
| NM_022559.1 | GH1 | Growth hormone 1 | 4.1 | 0.1 | 2.7 | 0.22 | 2.8 | 0.31 |
| NM_022561.1 | GH1 | Growth hormone 1 | 4.6 | 0.04 | 2.8 | 0.36 | 1.1 | 0.83 |
| NM_015895.1 | GMNN | Geminin DNA replication inhibitor | 1.8 | <0.01 | 1.8 | <0.01 | 1.0 | 0.81 |
| NM_006572.1 | GNA13 | Guanine nucleotide binding protein (G protein) alpha 13 | 2.6 | <0.01 | 1.3 | 0.55 | 2.1 | <0.01 |
| AB018301.1 | GPR116 | G protein-coupled receptor 116 | 3.3 | <0.01 | 5.4 | <0.01 | 1.6 | 0.35 |
| AB018301.1 | GPR116 | G protein-coupled receptor 116 | 1.9 | 0.1 | 2.2 | 0.07 | 1.2 | 0.59 |
| NM_005282.1 | GPR4 | G protein-coupled receptor 4 | 2.4 | <0.01 | 3.1 | 0.03 | 0.9 | 0.82 |
| U35399.1 | GPR4 | G protein-coupled receptor 4 | 2.0 | 0.01 | 1.8 | 0.17 | 1.0 | 0.98 |
| NM_005308.1 | GPRK5 | G protein-coupled receptor kinase 5 | 1.9 | <0.01 | 1.3 | 0.35 | 1.3 | 0.31 |
| W93728 | GUCY1B3 | Guanylate cyclase 1 soluble, beta 3 | 2.8 | <0.01 | 1.4 | 0.26 | 1.4 | 0.13 |
| AF020340.1 | GUCY1B3 | Guanylate cyclase 1 soluble, beta 3 | 2.4 | <0.01 | 1.3 | 0.34 | 1.1 | 0.77 |
| NM_006101.1 | HEC | Highly expressed in cancer, rich in leucine heptad repeats | 2.2 | <0.01 | 1.9 | 0.05 | 1.4 | 0.18 |
| NM_018063.1 | HELLS | Helicase lymphoid-specific | 4.1 | <0.01 | 3.0 | 0.09 | 0.8 | 0.83 |
| NM_012485.1 | HMMR | Hyaluronan-mediated motility receptor (RHAMM) | 2.2 | <0.01 | 1.8 | 0.01 | 1.5 | 0.1 |
| U29343.1 | HMMR | Hyaluronan-mediated motility receptor (RHAMM) | 1.9 | <0.01 | 1.4 | 0.02 | 1.3 | 0.14 |
| NM_002158.1 | HTLF human T-cell leukemia virus enhancer factor | 1.9 | 0.06 | 1.7 | 0.22 | 1.6 | 0.36 | |
| BE964655 | HUMGT198 A | GT198 complete ORF | 2.1 | 0.02 | 2.7 | 0.04 | 1.1 | 0.84 |
| NM_001552.1 | IGFBP4 | Insulin-like growth factor binding protein 4 | 2.1 | <0.01 | 1.9 | <0.01 | 1.2 | 0.45 |
| NM_002189.1 | IL15RA | Interleukin 15 receptor alpha | 1.7 | 0.03 | 1.9 | 0.06 | 1.1 | 0.76 |
| NM_002183.1 | IL3RA | Interleukin 3 receptor alpha (low affinity) | 6.8 | 0.06 | 8.7 | <0.01 | 1.1 | 0.95 |
| M96651.1 | IL5RA | Interleukin 5 receptor alpha | 2.8 | 0.01 | 2.5 | 0.04 | 1.3 | 0.6 |
| NM_002184.1 | IL6ST | Interleukin 6 signal transducer (gp130 oncostatin M receptor) | 2.1 | <0.01 | 1.3 | 0.42 | 1.5 | <0.01 |
| BE300521 | INSIG1 | Insulin-induced gene 1 | 1.6 | <0.01 | 1.0 | 0.87 | 1.2 | 0.16 |
| BE300521 | INSIG1 | Insulin-induced gene 1 | 1.6 | 0.02 | 0.8 | 0.63 | 1.3 | 0.28 |
| NM_005542.1 | INSIG1 | Insulin-induced gene 1 | 1.5 | 0.02 | 0.9 | 0.8 | 1.1 | 0.68 |
| AI247494 | IRS3L | Insulin receptor substrate 3-like | 2.0 | 0.01 | 1.8 | <0.01 | 1.3 | 0.19 |
| AV733308 | ITGA6 | Integrin alpha 6 | 4.0 | <0.01 | 2.2 | <0.01 | 1.3 | <0.01 |
| NM_000210.1 | ITGA6 | Integrin alpha 6 | 2.6 | <0.01 | 2.1 | <0.01 | 1.2 | 0.21 |
| NM_014288.1 | ITGB3BP | Integrin beta 3 binding protein (beta3-endonexin) | 1.5 | <0.01 | 1.4 | 0.07 | 1.1 | 0.37 |
| AF002256.1 | KIR2DL4 | Killer cell immunoglobulinlike receptor two domains, long cytoplasmic tail 4 | 1.7 | <0.01 | 1.4 | 0.41 | 1.5 | 0.23 |
| AF119835.1 | KITLG | KIT ligand | 3.9 | 0.02 | 2.8 | 0.06 | 2.9 | 0.02 |
| NM_004523.2 | KNSL1 | Kinesin-like 1 | 2.4 | <0.01 | 1.7 | <0.01 | 1.3 | 0.1 |
| AC002301 | KNSL4 | Kinesin-like 4 | 2.2 | <0.01 | 1.4 | 0.43 | 1.3 | 0.36 |
| AY026505.1 | KNSL6 | Kinesin-like 6 (mitotic centromere-associated kinesin) | 1.8 | <0.01 | 1.3 | 0.11 | 1.2 | 0.24 |
| U63743.1 | KNSL6 | Kinesin-like 6 (mitotic centromere-associated kinesin) | 1.8 | <0.01 | 1.5 | <0.01 | 1.1 | 0.39 |
| NM_020242.1 | KNSL7 | Kinesin-like 7 | 2.0 | 0.02 | 1.7 | 0.17 | 1.1 | 0.73 |
| NM_004690.2 | LATS1 | LATS large tumor suppressor homolog 1 (Drosophila) | 1.5 | 0.03 | 1.4 | 0.11 | 1.3 | 0.51 |
| S70123.1 | LDLR | Low-density lipoprotein receptor (familial hypercholesterolemia) | 2.3 | <0.01 | 1.1 | 0.82 | 1.2 | 0.38 |
| AI861942 | LDLR | Low-density lipoprotein receptor (familial hypercholesterolemia) | 2.1 | 0.02 | 1.1 | 0.9 | 1.1 | 0.73 |
| NM_013296.1 | LGN | LGN protein | 5.8 | <0.01 | 3.3 | 0.18 | 2.7 | 0.3 |
| W05463 | LOC51275 | Apoptosis-related protein PNAS-1 | 1.5 | 0.02 | 1.3 | 0.27 | 1.1 | 0.62 |
| NM_017522.1 | LRP8 | Low-density lipoprotein receptor-related protein 8, apolipoprotein e receptor | 1.7 | 0.02 | 1.3 | 0.29 | 1.0 | 0.83 |
| NM_002349.1 | LY75 | Lymphocyte antigen 75 | 3.7 | <0.01 | 3.8 | <0.01 | 1.5 | 0.56 |
| NM_002358.2 | MAD2L1 | MAD2 mitotic arrest deficient-like 1 (yeast) | 2.0 | <0.01 | 1.6 | <0.01 | 1.2 | 0.21 |
| NM_005903.1 | MADH5 | MAD mothers against decapentaplegic homolog 5 (Drosophila) | 1.7 | 0.09 | 1.6 | 0.32 | 1.4 | 0.54 |
| AA780381 | MAP2K3 | Mitogen-activated protein kinase kinase 3 | 1.7 | 0.04 | 3.4 | 0.02 | 0.9 | 0.84 |
| Z25432.1 | MAPK14 | Mitogen-activated protein kinase 14 | 1.6 | 0.06 | 0.8 | 0.65 | 1.3 | 0.43 |
| NM_021960.1 | MCL1 | Myeloid cell leukemia sequence 1 (BCL2-related) | 1.6 | <0.01 | 1.0 | 0.9 | 1.3 | 0.1 |
| NM_004526.1 | MCM2 | MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae) | 1.7 | <0.01 | 1.6 | <0.01 | 1.0 | 0.9 |
| AA807529 | MCM5 | MCM5 minichromosome maintenance deficient 5 cell division cycle 46 (S. cerevisiae) | 2.0 | <0.01 | 2.3 | <0.01 | 1.1 | 0.65 |
| NM_006739.1 | MCM5 | MCM5 minichromosome maintenance deficient 5 cell division cycle 46 (S. cerevisiae) | 2.1 | <0.01 | 1.7 | 0.1 | 1.0 | 0.83 |
| NM_002389.1 | MCP | Membrane cofactor protein (CD46 trophoblastlymphocyte cross-reactive antigen) | 1.7 | <0.01 | 1.1 | 0.74 | 1.2 | 0.01 |
| D84105.1 | MCP | Membrane cofactor protein (CD46 trophoblastlymphocyte cross-reactive antigen) | 1.8 | <0.01 | 1.0 | 0.98 | 1.2 | 0.11 |
| NM_014791.1 | MELK | Maternal embryonic leucine zipper kinase | 1.8 | <0.01 | 1.8 | <0.01 | 1.0 | 0.79 |
| NM_005924.1 | MEOX2 | Mesenchyme homeo box 2 (growth arrest-specific homeo box) | 3.3 | <0.01 | 2.1 | 0.23 | 1.6 | 0.47 |
| BG170541 | MET | Met proto-oncogene (hepatocyte growth factor receptor) | 1.7 | <0.01 | 1.4 | 0.27 | 1.3 | 0.25 |
| X54559.1 | MET | Met proto-oncogene (hepatocyte growth factor receptor) | 1.6 | <0.01 | 1.0 | 0.84 | 1.2 | 0.39 |
| BC005043.1 | MGC31957 | Hypothetical protein MGC31957 | 2.2 | 0.02 | 1.3 | 0.57 | 1.4 | 0.22 |
| BF001806 | MKI67 | Antigen identified by monoclonal antibody Ki-67 | 2.1 | <0.01 | 1.7 | 0.01 | 1.0 | 0.76 |
| Z69744 | MLL | Myeloid/lymphoid or mixedlineage leukemia (trithorax homolog Drosophila) | 1.7 | <0.01 | 1.2 | 0.44 | 1.4 | 0.03 |
| NM_016195.1 | MPHOSPH1 | M-phase phosphoprotein 1 | 1.9 | 0.01 | 1.8 | 0.2 | 1.2 | 0.58 |
| NM_006540.1 | NCOA2 | Nuclear receptor coactivator 2 | 2.0 | 0.05 | 2.0 | 0.3 | 2.1 | 0.01 |
| NM_002497.1 | NEK2 | NIMA (never in mitosis gene a)-related kinase 2 | 1.6 | 0.08 | 1.5 | 0.16 | 1.3 | 0.44 |
| Z25425.1 | NEK2 | NIMA (never in mitosis gene a)-related kinase 2 | 1.7 | 0.03 | 1.3 | 0.53 | 1.3 | 0.54 |
| Z25434.1 | NEK3 | NIMA (never in mitosis gene a)-related kinase 3 | 1.7 | 0.01 | 1.3 | 0.34 | 1.3 | 0.3 |
| NM_007361.1 | NID2 | Nidogen 2 (osteonidogen) | 2.1 | <0.01 | 2.4 | <0.01 | 1.0 | 0.83 |
| AF146343.1 | NR5A2 | Nuclear receptor subfamily 5, group a member 2 | 3.2 | 0.08 | 3.1 | 0.06 | 1.7 | 0.27 |
| AF228413.1 | NR5A2 | Nuclear receptor subfamily 5, group a member 2 | 4.3 | <0.01 | 3.0 | 0.07 | 1.4 | 0.62 |
| NM_003822.1 | NR5A2 | Nuclear receptor subfamily 5, group a member 2 | 1.9 | 0.08 | 1.5 | 0.38 | 1.1 | 0.84 |
| AF145712.1 | NRP1 | Neuropilin 1 | 2.0 | <0.01 | 1.1 | 0.77 | 1.5 | 0.09 |
| NM_003999.1 | OSMR | Oncostatin M receptor | 1.7 | 0.07 | 1.3 | 0.49 | 1.2 | 0.59 |
| NM_005746.1 | PBEF | Pre-B-cell colony-enhancing factor | 1.6 | <0.01 | 1.2 | 0.17 | 1.2 | 0.05 |
| BF575514 | PBEF | Pre-B-cell colony-enhancing factor | 1.5 | <0.01 | 1.2 | 0.12 | 1.1 | 0.1 |
| BC001422.1 | PGF | Placental growth factor, vascular endothelial growth factor-related protein | 1.5 | <0.01 | 1.7 | <0.01 | 1.2 | 0.06 |
| AA805318 | PIK3CB | Phosphoinositide-3-kinase, catalytic beta polypeptide | 1.7 | 0.09 | 1.1 | 0.73 | 1.4 | 0.3 |
| NM_004203.1 | PKMYT1 | Membrane-associated tyrosine- and threoninespecific cdc2-inhibitory kinase | 1.7 | 0.03 | 1.7 | 0.1 | 1.0 | 0.97 |
| NM_005030.1 | PLK | Polo-like kinase (Drosophila) | 1.6 | 0.02 | 1.3 | 0.21 | 1.1 | 0.82 |
| NM_025179.1 | PLXNA2 | Plexin A2 | 1.6 | 0.04 | 0.9 | 0.8 | 1.0 | 0.94 |
| NM_002674.1 | PMCH | Pro-melanin-concentrating hormone | 10.7 | <0.01 | 6.6 | <0.01 | 0.5 | 0.46 |
| BC002715.1 | PPARD | Peroxisome proliferative activated receptor delta | 2.7 | 0.06 | 2.1 | 0.21 | 0.8 | 0.79 |
| NM_003981.1 | PRC1 | Protein regulator of cytokinesis 1 | 2.4 | <0.01 | 2.0 | <0.01 | 1.3 | 0.24 |
| AF100763.1 | PRKAA1 | Protein kinase AMPactivated, alpha 1 catalytic subunit | 1.5 | <0.01 | 1.0 | 0.98 | 1.0 | 0.76 |
| NM_000315.1 | PTH | Parathyroid hormone | 1.8 | 0.08 | 1.9 | 0.07 | 2.2 | 0.07 |
| AF074979.1 | RGS20 | Regulator of G-protein signalling 20 | 2.6 | <0.01 | 2.7 | <0.01 | 1.2 | 0.59 |
| BF062629 | RIS1 | RAS-induced senescence 1 | 5.9 | <0.01 | 10.5 | <0.01 | 3.2 | 0.27 |
| NM_003035.1 | SIL | TAL1 (SCL) interrupting locus | 1.5 | 0.03 | 1.5 | 0.05 | 1.0 | 0.99 |
| BC001441.1 | SKP2 | S-phase kinase-associated protein 2 (p45) | 1.7 | <0.01 | 1.1 | 0.74 | 1.3 | 0.2 |
| NM_005983.1 | SKP2 | S-phase kinase-associated protein 2 (p45) | 3.7 | 0.05 | 1.1 | 0.76 | 0.9 | 0.89 |
| NM_006444.1 | SMC2L1 | SMC2 structural maintenance of chromosomes 2-like 1 (yeast) | 1.9 | <0.01 | 1.5 | <0.01 | 1.2 | 0.11 |
| AU154486 | SMC2L1 | SMC2 structural maintenance of chromosomes 2-like 1 (yeast) | 2.2 | <0.01 | 1.7 | 0.16 | 1.3 | 0.25 |
| BG035761 | SOCS3 | Suppressor of cytokine signaling 3 | 3.0 | 0.07 | 2.5 | 0.26 | 0.7 | 0.71 |
| NM_001049.1 | SSTR1 | Somatostatin receptor 1 | 3.1 | 0.05 | 2.0 | 0.39 | 1.1 | 0.88 |
| NM_003155.1 | STC1 | Stanniocalcin 1 | 22.8 | <0.01 | 2.6 | 0.02 | 0.8 | 0.53 |
| NM_005990.1 | STK10 | Serine/threonine kinase 10 | 2.3 | <0.01 | 2.4 | <0.01 | 1.0 | 0.84 |
| AB015718 | STK10 | Serine/threonine kinase 10 | 1.5 | <0.01 | 1.7 | <0.01 | 1.0 | 0.9 |
| AB011446.1 | STK12 | Serine/threonine kinase 12 | 1.9 | <0.01 | 1.6 | 0.06 | 1.1 | 0.51 |
| AL043646 | STK18 | Serine/threonine kinase 18 | 5.0 | <0.01 | 4.9 | <0.01 | 2.9 | 0.11 |
| NM_014264.1 | STK18 | Serine/threonine kinase 18 | 3.0 | <0.01 | 2.1 | 0.05 | 1.2 | 0.66 |
| NM_003158.1 | STK6 | Serine/threonine kinase 6 | 1.8 | <0.01 | 1.4 | 0.14 | 1.2 | 0.32 |
| NM_003600.1 | STK6 | Serine/threonine kinase 6 | 1.7 | <0.01 | 1.4 | 0.1 | 1.2 | 0.36 |
| NM_003242.1 | TGFBR2 | Transforming growth factor, beta receptor II (70/80 k Da) | 1.5 | 0.02 | 0.9 | 0.61 | 1.1 | 0.28 |
| NM_000361.1 | THBD | Thrombomodulin | 2.8 | <0.01 | 2.6 | <0.01 | 1.1 | 0.78 |
| NM_000361.1 | THBD | Thrombomodulin | 5.6 | <0.01 | 5.4 | <0.01 | 1.2 | 0.79 |
| AF153687.1 | TNFRSF10B | Tumor necrosis factor receptor superfamily member 10b | 1.8 | <0.01 | 0.9 | 0.58 | 1.2 | 0.17 |
| AF012536.1 | TNFRSF10C | Tumor necrosis factor receptor superfamily member 10c, decoy without an intracellular domain | 2.2 | <0.01 | 1.5 | 0.16 | 1.3 | 0.36 |
| NM_003841.1 | TNFRSF10C | Tumor necrosis factor receptor superfamily member 10c, decoy without an intracellular domain | 2.1 | <0.01 | 1.4 | 0.09 | 1.1 | 0.44 |
| BF664114 | TNFRSF5 | Tumor necrosis factor receptor superfamily member 5 | 2.3 | 0.01 | 1.9 | 0.03 | 0.8 | 0.49 |
| NM_001250.1 | TNFRSF5 | Tumor necrosis factor receptor superfamily member 5 | 4.7 | <0.01 | 2.8 | 0.02 | 1.1 | 0.65 |
| M15565.1 | TRA | T cell receptor alpha locus | 1.9 | 0.07 | 1.7 | 0.02 | 1.0 | 0.98 |
| NM_005879.1 | TRIP | TRAF interacting protein | 1.7 | 0.09 | 2.0 | 0.02 | 1.2 | 0.66 |
| NM_004237.1 | TRIP13 | Thyroid hormone receptor interactor 13 | 1.7 | <0.01 | 1.6 | 0.06 | 1.1 | 0.7 |
| NM_003318.1 | TTK | TTK protein kinase | 2.1 | <0.01 | 1.5 | 0.08 | 1.3 | 0.19 |
| AJ003062.1 | TUBGCP3 | Tubulin gamma complex-associated protein 3 | 1.6 | 0.03 | 1.3 | 0.39 | 1.2 | 0.65 |
| NM_007019.1 | UBE2C | Ubiquitin-conjugating enzyme E2C | 1.7 | <0.01 | 1.4 | 0.04 | 1.1 | 0.57 |
| NM_007063.1 | VRP | Vascular Rab-GAP/TBC containing | 2.0 | <0.01 | 1.7 | 0.01 | 1.2 | 0.12 |
| AI983115 | WSX1 | Class I cytokine receptor | 3.9 | <0.01 | 2.7 | 0.12 | 2.3 | 0.16 |
| NM_016164.2 | XLKD1 | Extracellular link domain containing 1 | 3.4 | 0.01 | 1.6 | 0.47 | 1.2 | 0.81 |
| Z25433.1 | Protein-serine/threonine kinase (Homo sapiens), mRNA sequence | 4.5 | <0.01 | 2.3 | 0.32 | 2.5 | 0.06 | |
| X07868 | Homo sapiens cDNA:FLJ22066 fis clone HEP10611 mRNA sequence | 2.9 | <0.01 | 3.8 | <0.01 | 1.4 | 0.23 | |
| AA058828 | Soluble vascular endothelial cell growth factor receptor (A49636) | 1.9 | <0.01 | 1.6 | 0.03 | 1.1 | 0.45 | |
| AA351360 | KIAA0585 protein (Homo sapiens) (AB011157) | 2.0 | <0.01 | 1.4 | 0.74 | 1.2 | 0.86 |